Functional outcome of two-stage reimplantation in patients with periprosthetic joint infection after primary total knee arthroplasty

2019 ◽  
Vol 43 (11) ◽  
pp. 2503-2509 ◽  
Author(s):  
Petr Mikhailovich Preobrazhensky ◽  
Svetlana Anatolievna Bozhkova ◽  
Alexander Viktorovich Kazemirsky ◽  
Rashid Murtazalievich Tikhilov ◽  
Taras Andreevich Kulaba ◽  
...  
2022 ◽  
Vol 3 (1) ◽  
pp. 35-41
Author(s):  
Daniel B. Buchalter ◽  
Afamefuna Nduaguba ◽  
Greg M. Teo ◽  
David Kugelman ◽  
Vinay K. Aggarwal ◽  
...  

Aims Despite recent literature questioning their use, vancomycin and clindamycin often substitute cefazolin as the preoperative antibiotic prophylaxis in primary total knee arthroplasty (TKA), especially in the setting of documented allergy to penicillin. Topical povidone-iodine lavage and vancomycin powder (VIP) are adjuncts that may further broaden antimicrobial coverage, and have shown some promise in recent investigations. The purpose of this study, therefore, is to compare the risk of acute periprosthetic joint infection (PJI) in primary TKA patients who received cefazolin and VIP to those who received a non-cephalosporin alternative and VIP. Methods This was a retrospective cohort study of 11,550 primary TKAs performed at an orthopaedic hospital between 2013 and 2019. The primary outcome was PJI occurring within 90 days of surgery. Patients were stratified into two groups (cefazolin vs non-cephalosporin) based on their preoperative antibiotic. All patients also received the VIP protocol at wound closure. Bivariate and multiple logistic regression analyses were performed to control for potential confounders and identify the odds ratio of PJI. Results In all, 10,484 knees (90.8%) received cefazolin, while 1,066 knees (9.2%) received a non-cephalosporin agent (either vancomycin or clindamycin) as preoperative prophylaxis. The rate of PJI in the cefazolin group (0.5%; 48/10,484) was significantly lower than the rate of PJI in the non-cephalosporin group (1.0%; 11/1,066) (p = 0.012). After controlling for confounding variables, the odds ratio (OR) of developing a PJI was increased in the non-cephalosporin cohort compared to the cefazolin cohort (OR 2.389; 1.2 to 4.6); p = 0.01). Conclusion Despite the use of topical irrigant solutions and addition of local antimicrobial agents, the use of a non-cephalosporin perioperative antibiotic continues to be associated with a greater risk of TKA PJI compared to cefazolin. Strategies that increase the proportion of patients receiving cefazolin rather than non-cephalosporin alternatives must be emphasized. Cite this article: Bone Jt Open 2022;3(1):35–41.


2020 ◽  
Vol 35 (12) ◽  
pp. 3668-3672 ◽  
Author(s):  
Ashton H. Goldman ◽  
Douglas R. Osmon ◽  
Arlen D. Hanssen ◽  
Mark W. Pagnano ◽  
Daniel J. Berry ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document